Activists Urge Action on Cancer Medicine Access

Activists are demanding an expedited decision from the Kerala High Court regarding a long-standing case that seeks better access to life-saving breast cancer medication. The Working Group on Access to Medicines and Treatment has expressed deep frustration over the procedural delays, noting that the writ petition has been listed for a final hearing 57 times without reaching a conclusion. This case has remained pending before the court since June 2022, effectively stalling critical progress on medicine availability and affordability for patients.

The advocacy group highlights that the current lack of judicial finality disproportionately affects patients who rely on timely access to these essential medicines. Despite multiple opportunities to address the petition since early 2023, the absence of a decisive hearing has left stakeholders in a state of uncertainty. Activists argue that the bureaucratic backlog is creating unnecessary barriers to healthcare, with many patients unable to afford the high costs of treatment currently associated with these life-saving therapies.

The ongoing delay underscores the broader challenges in India regarding the accessibility of specialized oncology drugs. By keeping the petition in a state of perpetual postponement, the court’s inaction has become a central point of criticism for those striving to improve the national health framework. As the legal situation remains frozen, patients and their families continue to endure the consequences of high drug prices and limited support, reinforcing the urgency for a court-mandated resolution to expand treatment access for breast cancer patients nationwide.